Landmark results of new and exciting organosilicon chemistry possible because two highly specialized expert groups collaborated their talent to conduct research.
Dr. Mathew Farrer is the UBC inaugural Canada Excellence Research Chair in neurogenetics and translational neuroscience---areas of research driven forward by TRIUMF's supply of innovative imaging agents using medical isotopes.
About forty members of the Generation-IV Interational Forum Policy Group (hailing from thirteen different countries) visited TRIUMF on Tuesday for a tour before meeting to discuss the future of nuclear power.
Phil Freeman, teacher at Richmond Secondary School, is awarded the first ever CAP High School Physics Teacher Award for the BC region for his contributions to physics education. Congratulations!
TRIUMF and Stanford University organized the 10th international workshop which explored techniques and topics related to Stopping and Manipulation of Ions.
The Government of Canada released its "Response to the Report of the Expert Review Panel on Medical-Isotope Production." TRIUMF is positioned to play a major role with cyclotrons and linear accelerators.
Dr. Art McDonald was among five recipients of the 2010 Killam Prize, one of Canada's most prestigious awards for outstanding career achievements. TRIUMF works with Dr. McDonald on the SNO project.
Three cryomodules have just been completed on schedule and on budget, allowing TRIUMF researchers to open up a whole new realm of nuclear structure experiments!
This morning at 1:06 p.m. CEST in Geneva, Switzerland, the LHC began colliding particle beams at the highest energies ever reached by a man-made accelerator.